Ovarian Sertoli-Leydig Cell Tumor with Elevated Inhibin B as a Cause of Secondary Amenorrhea in an Adolescent with Germ Line DICER1 Mutation
Amy M. Luke(San Antonio Uniformed Services Health Education Consortium), Susan L. Whiteway(Uniformed Services University of the Health Sciences), John W. Moroney(University of Chicago), Andrea N. Snitchler(Walter Reed National Military Medical Center)
Cited by 8
Related Papers
Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells
|Journal of Neuro-Oncology|2012|67
Phase III MIRASOL (GOG 3045/ENGOT-ov55) study: Initial report of mirvetuximab soravtansine vs. investigator's choice of chemotherapy in platinum-resistant, advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate receptor-alpha expression.
|Journal of Clinical Oncology|2023|53
Targetable molecular alterations in congenital glioblastoma
|Journal of Neuro-Oncology|2019|39
A phase Ib study of the anti-CD47 antibody magrolimab with the PD-L1 inhibitor avelumab (A) in solid tumor (ST) and ovarian cancer (OC) patients.
|Journal of Clinical Oncology|2020|37
Healthcare providers’ promotion of physical activity among child and adolescent cancer survivors: strategies and challenges
|Journal of Cancer Survivorship|2022|13